Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Int J Biol Macromol ; 189: 44-52, 2021 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-34419537

RESUMO

Congenital cataracts, which are genetically heterogeneous eye disorders, lead to visual impairment in childhood. In our previous study, we identified a novel mutation in exon 4 of the CRYBA1/BA3 gene, which resulted in the deletion of a highly conserved glycine at codon 91 (G91del) and perinuclear zonular cataract. The G91del variant is one of the most frequent pathogenic mutations in CRYBA1/BA3; however, its pathogenic mechanism remains unclear. In this study, we purified ßA3-crystallin and the ßA3-G91del variant. ßA3-G91del was prone to proteolysis and exhibited very low solubility and low structural stability. Next, we constructed a CRYBA1/BA3 mutant cell model and observed that G91del mutant proteins were more sensitive to environmental stress and prone to form aggregates. Size-exclusion chromatography and molecular dynamics simulation showed that the G91del mutation impaired the ability of ßA3 to form homo-oligomers. In addition, the protein folding process of ßA3-G91del was complicated and showed more intermediate states, resulting in amyloid fiber aggregation and induction of cellular apoptosis. Finally, we investigated intervention strategies for congenital cataract caused by the CRYBA1/A3-G91del variant. The addition of lanosterol reversed the negative effects of the G91del mutation under external stress. This study may help explore potential treatment strategies for related cataracts.


Assuntos
Catarata/congênito , Catarata/genética , Predisposição Genética para Doença , Mutação/genética , Cadeia A de beta-Cristalina/genética , Apoptose/efeitos dos fármacos , Linhagem Celular , Guanidina/farmacologia , Humanos , Interações Hidrofóbicas e Hidrofílicas , Lanosterol/farmacologia , Proteínas Mutantes/química , Proteínas Mutantes/metabolismo , Agregados Proteicos/efeitos dos fármacos , Desnaturação Proteica , Temperatura , Cadeia A de beta-Cristalina/química , Cadeia A de beta-Cristalina/ultraestrutura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...